eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | retinal vein occlusion |
| Symptom | C0271051|macular oedema |
| Sentences | 31 |
| PubMedID- 22833773 | Perifoveal microcirculation in macular oedema with retinal vein occlusion. |
| PubMedID- 19563372 | Purpose: this study aimed to investigate whether vascular endothelial growth factor (vegf) or interleukin-6 (il-6) influence macular oedema in patients with central retinal vein occlusion (crvo). |
| PubMedID- 23077221 | Association of electroretinographic parameters and inflammatory factors in branch retinal vein occlusion with macular oedema. |
| PubMedID- 25138756 | Sequential therapy with ranibizumab and dexamethasone intravitreal implant is better than dexamethasone monotherapy for macular oedema due to retinal vein occlusion. |
| PubMedID- 21913147 | New developments in the pharmacological treatment of macular oedema due to retinal vein occlusion. |
| PubMedID- 22132711 | Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion. |
| PubMedID- 26149584 | Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study. |
| PubMedID- 21947148 | Branch retinal vein occlusion with macular oedema is an additional finding in our study, which has not been previously reported. |
| PubMedID- 21751750 | macular oedema is one of the complications of retinal vein occlusion. |
| PubMedID- 21109696 | Role of soluble vascular endothelial growth factor receptor-2 in macular oedema with central retinal vein occlusion. |
| PubMedID- 23712192 | Prospective pilot study: efficacy of intravitreal dexamethasone and bevacizumab injections in the treatment of macular oedema associated with branch retinal vein occlusion. |
| PubMedID- 23016250 | In practice, the decision to grant marketing authorisation for ranibizumab in macular oedema due to retinal vein occlusion was premature. |
| PubMedID- 20456252 | Chemokines in aqueous humour before and after intravitreal triamcinolone acetonide in eyes with macular oedema associated with branch retinal vein occlusion. |
| PubMedID- 26197958 | Purpose: the present study investigated the treatment effect of dexamethasone implant (ozurdex(r), group 1) and anti-vegf injection (lucentis(r), group 2) in course of macular oedema due to retinal vein occlusion in a retrospective, non-randomised case series. |
| PubMedID- 20494908 | Purpose: to evaluate the efficacy and safety of simultaneous intravitreal injection of triamcinolone acetonide (ta) and tissue plasminogen activator (tpa) for macular oedema associated with central retinal vein occlusion (crvo). |
| PubMedID- 22415022 | Vascular endothelial growth factor receptor-2 in macular oedema with retinal vein occlusion. |
| PubMedID- 20111061 | Purpose: to investigate whether interleukine-8 (il-8) and monocyte chemoattractant protein-1 (mcp-1) are related with macular oedema in patients with branch retinal vein occlusions (brvos). |
| PubMedID- 25631483 | Purpose: to assess the efficacy and safety of intravitreal bevacizumab (ivb) compared with ranibizumab (ivr) in the treatment of macular oedema due to branch retinal vein occlusion (brvo). |
| PubMedID- 22863290 | Macular hole after injection of dexamethasone intravitreal implant for macular oedema due to central retinal vein occlusion. |
| PubMedID- 20339391 | Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion. |
| PubMedID- 22653519 | Relationship between perifoveal capillaries and pathomorphology in macular oedema associated with branch retinal vein occlusion. |
| PubMedID- 20679089 | Background: the purpose of this study is to evaluate the efficacy of intravitreal bevacizumab as the primary treatment of macular oedema due to retinal vein occlusions. |
| PubMedID- 23153657 | Grid laser photocoagulation for macular oedema due to branch retinal vein occlusion in the age of bevacizumab. |
| PubMedID- 21155986 | Purpose: to investigate the correlation between integrity of foveal photoreceptor layer and initial as well as final visual acuity (va) after successful resolution of macular oedema (me) associated with retinal vein occlusion (rvo). |
| PubMedID- 25777815 | Background/aims: to compare the functional and anatomical outcomes of intravitreal bevacizumab (ivb) with those of dexamethasone implant injection (ivd) for macular oedema associated with branch retinal vein occlusion (brvo). |
| PubMedID- 24513867 | Antithrombotics, such as low-molecular weight heparin (lmwh), and fibrinolytics have also been found to benefit visual acuity in retinal vein occlusion with no associated macular oedema. |
| PubMedID- 25619682 | Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study. |
| PubMedID- 25989706 | Purpose: to investigate whether targeted retinal photocoagulation (trp) of peripheral non-perfused areas (npas) could prevent the recurrence of macular oedema (me) due to branch retinal vein occlusion (brvo) after intravitreal bevacizumab injection (ivb). |
| PubMedID- 19696805 | Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion. |
| PubMedID- 25503473 | Purpose: to retrospectively evaluate the re-injection interval, efficacy and safety of dexamethasone (dex) intravitreal implant 0.7 mg in the treatment of macular oedema (me) due to retinal vein occlusion (rvo) in germany in 2009-2012. |
| PubMedID- 26533906 | Challenges to the economic modelling of macular oedema due to retinal vein occlusion and diabetes. |
Page: 1